v3.25.0.1
Revenues from Contracts with Customers - Summary of Disaggregation of Revenues from Contracts with Customers (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 2,751.1 € 3,819.0 € 17,310.6
Percentage of entity's revenue 100.00% 100.00% 100.00%
United States      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 1,847.8 € 3,010.9 € 12,709.7
Percentage of entity's revenue 67.00% 79.00% 73.00%
Germany      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 706.9 € 482.7 € 3,031.0
Percentage of entity's revenue 26.00% 13.00% 18.00%
Rest of the World      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 196.4 € 325.4 € 1,569.9
Percentage of entity's revenue 7.00% 8.00% 9.00%
Pfizer Inc.      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 2,011.7 € 3,293.0 € 13,795.8
Percentage of entity's revenue 73.00% 86.00% 80.00%
German Federal Ministry of Health      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 701.0 € 473.6 € 3,020.5
Percentage of entity's revenue 25.00% 12.00% 17.00%
Other Customers      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 38.4 € 52.4 € 494.3
Percentage of entity's revenue 2.00% 2.00% 3.00%
COVID-19 vaccine revenues      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 2,432.1 € 3,776.2 € 17,145.2
Percentage of entity's revenue 88.00% 99.00% 99.00%
Other revenues      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenues € 319.0 € 42.8 € 165.4
Percentage of entity's revenue 12.00% 1.00% 1.00%